Saif Al Yaarubi
Overview
Explore the profile of Saif Al Yaarubi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Sanctis V, Canatan D, Daar S, Kattamis C, Banchev A, Modeva I, et al.
Mediterr J Hematol Infect Dis
. 2025 Jan;
17(1):e2025008.
PMID: 39830799
Background: Current guidelines for screening glucose dysregulation (GD) in patients with transfusion-dependent thalassemia (TDT) recommend an annual 2-hour oral glucose tolerance test (OGTT) starting at the age of 10 years....
2.
Al Yaarubi S, Alsagheir A, Al Shidhani A, Alzelaye S, Alghazir N, Brema I, et al.
Orphanet J Rare Dis
. 2024 Mar;
19(1):118.
PMID: 38481246
Background: Congenital generalized lipodystrophy (CGL) is a rare inherited disease characterized by a near-total absence of adipose tissue and is associated with organ system abnormalities and severe metabolic complications. Here,...
3.
Babiker A, Elbarbary N, Alaqeel B, Al Noaim K, Al Yaarubi S, Al-Abdulrazzaq D, et al.
Clin Med Insights Endocrinol Diabetes
. 2023 Oct;
16:11795514231203907.
PMID: 37867504
Background: Lockdown was a unique experience that affected many aspects of life, particularly during the challenge of Ramadan fasting (RF). Studying this can increase understanding of the effects of lifestyle...
4.
Khater D, Al-Mulaabed S, Alomairi A, Elshinawy M, Soliman A, Elshinawy N, et al.
Hemoglobin
. 2023 Sep;
47(4):157-162.
PMID: 37691435
Growth impairment is a known complication of sickle cell disease (SCD). Few studies explored the potential effects of hydroxyurea (HU) on growth in children with SCD in relation to HU...
5.
Deeb A, Al Yaarubi S, Bin Abbas B, Al Jubeh J, Chaturvedi D, Al Hassani N, et al.
Front Pediatr
. 2022 Mar;
10:839278.
PMID: 35295698
Objective: This study aimed to assess patient perceptions of the use of the EasyPod™ growth hormone delivery device and its association with compliance. Methods: This cross-sectional, multicenter study was conducted...
6.
Elbarbary N, Moser O, Al Yaarubi S, AlSaffar H, Shaikh A, Ajjan R, et al.
Diab Vasc Dis Res
. 2021 Dec;
18(6):14791641211062155.
PMID: 34898300
Early control of glycaemia is key to reduce vascular complications in individuals with Type 1 diabetes. Therefore, encouraging children and adolescents with T1DM to take responsibility for controlling glucose levels...
7.
Al Shidhani A, Al Hinai A, Al Thihli K, Al Mandhari H, Al Yaarubi S, Ullah I, et al.
J Clin Res Pediatr Endocrinol
. 2021 Nov;
15(3):302-306.
PMID: 34738771
Congenital hyperinsulinism (CHI) is the most common cause of persistent hypoglycemia in infancy. CHI is a challenging disease to diagnose and manage. Moreover, complicating the course of the disease with...
8.
Al Shidhani A, Ullah I, AlSaffar H, Al Kindi A, Al Nabhani H, Al Yaarubi S
Oman Med J
. 2021 Feb;
36(1):e226.
PMID: 33628462
The physiological actions of thyroid hormone (TH) are mediated through TH alpha and TH beta receptors. Resistance to TH (RTH) is characterized by a lack of peripheral tissues' response to...
9.
De Sanctis V, Soliman A, Elsedfy H, Albu A, Al Jaouni S, Anastasi S, et al.
Mediterr J Hematol Infect Dis
. 2017 Jan;
9(1):e2017001.
PMID: 28101307
Background: Multi-transfused thalassemia major (TM) patients frequently develop severe endocrine complications, mainly due to iron overload, anemia, and chronic liver disease, which require prompt diagnosis, treatment and follow-up by specialists....
10.
De Sanctis V, Soliman A, Elsedfy H, Al Yaarubi S, Skordis N, Khater D, et al.
Mediterr J Hematol Infect Dis
. 2016 Nov;
8(1):e2016058.
PMID: 27872738
Iron overload in patients with thalassemia major (TM) affects glucose regulation and is mediated by several mechanisms. The pathogenesis of glycaemic abnormalities in TM is complex and multifactorial. It has...